Keyphrases
Distant Metastasis
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Cetuximab
100%
Recurrent Metastatic
100%
Treatment Outcome
100%
Locoregional Recurrence
100%
Locoregional
100%
Progression-free Survival
37%
Disease Control Rate
37%
Clinical Outcomes
25%
Overall Survival
25%
Clinical Features
25%
Survival Outcomes
25%
Salvage Surgery
25%
Multivariate Analysis
12%
Risk Factors
12%
Therapeutic Efficacy
12%
Poor Clinical Outcomes
12%
Prognostic Factors
12%
Treatment Choice
12%
Rate Control
12%
Head-and-neck
12%
Recurrent Disease
12%
Radiation Therapy
12%
Clinical Factors
12%
Oral Cavity Cancer
12%
Disease Control
12%
Squamous Cell Carcinoma of Head
12%
Difficult-to-treat
12%
Objective Response Rate
12%
Median Overall Survival
12%
Disease Survival
12%
Metastatic Squamous Cell Carcinoma
12%
Overall Survival Progression-free Survival
12%
Limited Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Head and Neck Squamous Cell Carcinoma
100%
Cetuximab
100%
Diseases
55%
Overall Survival
44%
Progression Free Survival
44%
Clinical Feature
22%
Distant Metastasis
22%
Combination Therapy
11%
Retrospective Study
11%
Mouth Cancer
11%
Squamous Cell Carcinoma
11%